1. Department of General Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China 2. Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China 3. Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China 4. Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
Chronic disseminated intravascular coagulation (DIC) is a rare but devastating complication of aortic aneurysm (AA). This study investigated the clinical manifestations, laboratory findings, and treatment of patients with AA-associated chronic DIC (AA-DIC) and explored the mechanisms, duration, and therapeutic response of AA-DIC. We retrospectively reviewed the medical records of 235 AA patients admitted at the Peking Union Medical College Hospital between September 2009 and January 2015. The patients were classified as those with DIC (AA-DIC) and those without DIC (non-DIC). The AA-DIC group showed a significantly higher proportion of female patients and a significantly longer AA disease course than the non-DIC group did. The AA-DIC patients presented mural thrombi, dissecting aneurysms, a family history of AA, and diabetes significantly more frequently than the non-DIC patients did. Furthermore, multiple regression analyses revealed that sex, mural thrombus, aneurysm type, diabetes, and stent surgery are possible independent risk factors for AA-DIC patients. Fifty-two (22.1%) patients presented AA-DIC. Among these patients, 43 had non-typical DIC and 9 had typical DIC; the mortality rate of the latter was 22.2%. The mean age of the patients with typical DIC was significantly higher than of that of patients with non-typical DIC. The non-typical DIC patients also presented abnormal coagulation disorders of varying degrees. Furthermore, heparin or low-molecular-weight heparin improved the clinical symptoms and laboratory parameters in patients with AA and typical DIC. Thus, chronic DIC should be considered in patients with AA.
Hayashi T, Nakagawa N, Kadohira Y, Morishita E, Asakura H. Rivaroxaban in a patient with disseminated intravascular coagulation associated with an aortic aneurysm: a case report. Ann Intern Med 2014; 161(2): 158–159
https://doi.org/10.7326/L14-5014-3
pmid: 25023258
27
Hoshina K, Shigematsu K, Hosaka A, Okamoto H, Miyata T, Watanabe T. The effect of recombinant human soluble thrombomodulin on disseminated intravascular coagulation in an abdominal aortic aneurysm. Blood Coagul Fibrinolysis 2014; 25(4): 389–391
https://doi.org/10.1097/MBC.0000000000000031
pmid: 24378974
1
Kasper DL, Harrison TR. Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Medical Pub Division, 2005
2
Bick RL. Disseminated intravascular coagulation: current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematol Oncol Clin North Am 2003; 17(1): 149–176
https://doi.org/10.1016/S0889-8588(02)00102-8
pmid: 12627667
3
Wada H, Gabazza EC, Asakura H, Koike K, Okamoto K, Maruyama I, Shiku H, Nobori T. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003; 74(1): 17–22
https://doi.org/10.1002/ajh.10377
pmid: 12949885
Jeleńska MM. Coagulation parameters as predictors of DIC in patients with intact aortic aneurysm. Hamostaseologie 2004; 24(3): 162–166
pmid: 15314700
Fernandez-Bustamante A, Jimeno A. Disseminated intravascular coagulopathy in aortic aneurysms. Eur J Intern Med 2005; 16(8): 551–560 PMID:16314235
https://doi.org/10.1016/j.ejim.2005.06.015
Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86(5): 1327–1330
pmid: 11816725
10
Fisher DF Jr, Yawn DH, Crawford ES. Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg 1983; 118(11): 1252–1255
https://doi.org/10.1001/archsurg.1983.01390110010002
pmid: 6639333
11
Jimeno A, Toledo T, Moya I, González-Barber A. Chronic disseminated intravascular coagulation caused by an aorto-bifemoral aneurysm. Eur J Intern Med 2005; 16(4): 298–300
https://doi.org/10.1016/j.ejim.2004.11.012
pmid: 16084360
12
Liu W, Zhang L, Liu Y, Liu X, Xue F, Chen Y, Huang Y, Yang R. Chronic disseminated intravascular coagulopathy associated with aortic dissecting aneurysms: two cases report and literature review. Chin J Hematol (Zhonghua Xue Ye Xue Za Zhi) 2014; 35(9): 831–834 (in Chinese) PMID:25246253
13
Levi M, de Jonge E, van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 2004; 36(1): 41–49
https://doi.org/10.1080/07853890310017251
pmid: 15000346
Straub PW, Kessler S. Metabolism and localization of 131I-fibrinogen in chronic intravascular coagulation. Schweiz Med Wochenschr 1970; 100(46): 2001–2003 (in German) PMID:5507850
16
Carroccio A, Ellozy SH, Marin ML, Hollier LH. Ten years’ experience treating abdominal aortic aneurysms with stent-grafts. Adv Surg 2004; 38: 267–280
pmid: 15515622
17
Sakamoto I, Matsuyama N, Fukushima A, Hayashi H, Nishida A, Hazama S, Noguchi M, Eishi K, Hayashi K. Chronic aortic dissection complicated by disseminated intravascular coagulation: successful treatment with endovascular stent-grafting. J Endovasc Ther 2003; 10(5): 953–957
https://doi.org/10.1177/152660280301000519
pmid: 14656174
Mueller MM, Bomke B, Seifried E. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Thromb Res 2002; 107(Suppl 1): S9–S17
https://doi.org/10.1016/S0049-3848(02)00146-9
pmid: 12379287
22
Tsuji T, Morikawa K, Hirano T, Yamasaki H, Tsuda H. Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection. Rinsho Ketsueki 2013; 54(8): 769–771 (in Japanese)
pmid: 24005438
23
Hoshina K, Kaneko M, Hosaka A, Okamoto H, Shigematsu K, Miyata T. Lessons learned from a case of abdominal aortic aneurysm accompanied by unstable coagulopathy. Case Rep Vasc Med 2012; 2012:265860
24
Iyama S, Sato T, Murase K, Kamihara Y, Ono K, Kikuchi S, Takada K, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J. Intermittent administration of recombinant human soluble thrombomodulin successfully controlled chronic disseminated intravascular coagulation in a patient with dissecting aortic aneurysm on an outpatient basis. Blood Coagul Fibrinolysis 2012; 23(6): 548–550
https://doi.org/10.1097/MBC.0b013e32835510d6
pmid: 22732250
25
Hayakawa K, Tamura S, Gima H, Hayakawa T, Kurihara T, Ooura M, Nakano Y, Souri M, Ichinose A, Fujimoto T. Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm. Rinsho Ketsueki 2014; 55(11): 2300–2305
pmid: 25501411